This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Johns Hopkins University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024-2026
Title: Poulami Majumder: Innovator in Peptide Hydrogel Technology
Introduction
Poulami Majumder is a distinguished inventor based in Frederick, MD (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of peptide hydrogels for drug delivery applications. With a total of 2 patents, her work is paving the way for innovative solutions in medicine.
Latest Patents
Majumder's latest patents include "Peptide Hydrogels for Delivery of Immunosuppressive Drugs and Uses Thereof" and "Nanoparticle-Hydrogel Composite for Nucleic Acid Molecule Delivery." These patents describe novel peptide hydrogels that contain encapsulated nanoparticles comprising nucleic acid molecules, such as miRNA. The technology allows for multiple gel-to-solution and solution-to-gel phase transitions, enabling controlled delivery of nucleic acid molecules to subjects.
Career Highlights
Throughout her career, Poulami Majumder has worked with prestigious organizations, including Johns Hopkins University and the United States Department of Health and Human Services. Her research has focused on advancing drug delivery systems, which are crucial for improving patient outcomes in various medical treatments.
Collaborations
Majumder has collaborated with notable professionals in her field, including Joel Patrick Schneider and Anand Singh. These partnerships have enhanced her research and contributed to the successful development of her patented technologies.
Conclusion
Poulami Majumder is a pioneering inventor whose work in peptide hydrogels is making a significant impact in the field of drug delivery. Her innovative patents and collaborations highlight her commitment to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile